KLRK1 and neoplasm: The membrane-bound ligands binding to NKG2D play an important role in NK cell activation and tumor immune surveillance (247, 252, 253), while the soluble NKG2D ligands suppress tumor immunity by passively blocking NKG2D and inducing receptor internalization to down-regulate NKG2D on the surface of NK cells (254–256).